Modulation of immunity by levamisole
Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors - Tập 2 - Trang 397-423 - 1978
Tài liệu tham khảo
Al-Ibrahim, 1975, Stimulation of human macrophages in vitro by levamisole, Clin. Res., 23, 286A
Amery, 1975, Immunopotentiation with levamisole in resectable bronchogenic carcinoma. A double-blind placebo-controlled trial, Br. med. J., 3, 461, 10.1136/bmj.3.5981.461
Anderson, 1976, in vitro stimulation of neutrophil mobility by levamisole: maintenance of cGMP levels in chemotactically stimulated levamisolc-treated neutrophils, J. Immun., 117, 428, 10.4049/jimmunol.117.2.428
Argyris, 1974, Role of macrophages in the immune response, 27
Benoist, 1976, Un nouveau cas d’agranulocytose au cours d’une polyarthrite tritée par le levamisole, Nouv. Presse Med., 5, 2474
Bertrand, 1974, Maladie de Crohn et levamisole, Nouv. Presse Med., 3, 2265
Biniaminov, 1975, In vitro restoration by levamisole of thymo-dcrived lymphocyte function in Hodgkin's disease, Lancet, i, 464, 10.1016/S0140-6736(75)91543-3
Carli-Basset, 1976, Levamisole et maladies autoimmunes dermatologiques. S. F. derm. Syph. filiale Ouest et Sud Ouest Toulouse 11/12/76, Ann. dermato. venereologie
Chan, 1975, Levamisole and lymphocyte responsiveness, Lancet, ii, 1246, 10.1016/S0140-6736(75)92243-6
Chirigos, 1973, Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant, Cancer Res., 33, 2615
Chirigos, 1974, Effect of tumor load reduction on successful immunostimulation, Proc. Am. Ass. Cancer Res., 15, 116
Chirigos, 1975, Prolongation of chemotherapeutically induced remission of a syngeneic murine leukemia by 1–2, 3, 5, 6-tetrahydro-6-phenylimidazolc (2, 1-β) thiazole hydrochloride, Cancer Res., 35, 927
Colpaert, 1975, A critical study on RO-4-1284 antagonism in mice, Archs int. Pharmdcodyn. Ther., 215, 40
Copeland, 1974, Effect of levamisole (NSC-177023) on in vitro human lymphocyte transformation, Cancer Chemother. Rep., 58, 167
DeDiego, 1974, Influencia de los antiparasitarios sistemicos sobre las aglutininas. I. Aglutininas producidas por vacuna, Gac. vet., 36, 164
DeDiego, 1974, Influencia de los antiparasitarios sistemicos sobre las aglutininas. II. Aglutininas de vacas enfermas, Gac. vet., 36, 584
Desowitz, 1975, Plasmodium berghei: immunogenic enhancement of antigen by adjuvant addition, Expl. Parasit., 38, 6, 10.1016/0014-4894(75)90032-6
Douglas, 1976, Effects of levamisole on monocyte-macrophage immunoprotein receptors and in vitro function, Fedn Proc., 35, 335
Durand, 1942, Recherche du pouvoir neutralisant du sérum des vaccinés contre le typhus exanthematique, Bull. Acad. Med., 126, 410
Eyre, 1970, Some pharmacodynamic effects of the nematocides: methyridine, tetramisole and pyrantel, J. Pharm. Pharmac., 22, 26, 10.1111/j.2042-7158.1970.tb08380.x
Faguet, 1973, Lymphocyte sensitivity and cellular immunity in neoplasia, Biomedicine, 19, 43
Fidler, 1975, Effects of levamisole on in vivo and in vitro murine host response to syngeneic transplantable tumor, J. natn. Cancer Inst., 55, 1107, 10.1093/jnci/55.5.1107
Fischer, 1975, Enhanced host defense mechanisms with levamisole in suckling rats, J. infect. Dis., 132, 578, 10.1093/infdis/132.5.578
Goldberg, 1973, The biological role of cyclic 3′,5′guanosine monophosphate, 146
Goldberg, 1974, Evidence for a dualism between cyclic GMP and cyclic AMP in the regulation of cell proliferation and other cellular processes, 247
Golding, 1976, In vitro reversal of cellular unresponsiveness induced by levamisole, Clin. Exp. Immun., 26, 295
Gordon, 1975, The treatment of systemic lupus erythematosus (SLE) with the T-cell immunostimulant drug levamisole, a case report, Ann. Allergy, 35, 343
Goyanes-Villaescusa, 1976, Mitogenic stimulation by levamisole on normal human lymphocytes and leukaemic lymphoblasts, Lancet, i, 370, 10.1016/S0140-6736(76)90134-3
Hadden, 1975, Cyclic nucleotides in lymphocyte function, Vol. 256, 352
Hadden, 1974, Levamisole, cyclic nucleotides and immunopharmacology, 353
Hadden, 1975, Effects of levamisole and imidazole on lymphocyte proliferation and cyclic nucleotide levels, Cellular Immun., 20, 98, 10.1016/0008-8749(75)90088-X
Hirshaut, 1973, Effects of levamisole on delayed hypersensitivity reactions in cancer patients, Proc. Am. Ass. Cancer Res., 14, 109
Hoebeke, 1973, Influence of Tetramisole and its optical isomers on the mononuclear phagocytic system. Effect on carbon clearance in mice, J. Reticuloendothelial Soc., 14, 317
Hokama, 1974, Effects of levamisole and C-reactive protein on mitogen stimulated lymphocytes in vitro and on the Cx-reactive protein response in vivo, Fedn Proc., 33, 650
Holebrook, 1967, Polarographic determination of tetramisole hydrochloride in extracts of animal tissue, Analyt. Biochem., 18, 46, 10.1016/0003-2697(67)90054-1
Hopper, 1975, Levamisole treatment of local and metastatic growth of transplanted rat tumours, Br. J. Cancer, 32, 345, 10.1038/bjc.1975.233
Huskisson, 1976, Immunostimulant therapy with levamisole for rheumatoid arthritis, Lancet, i, 393, 10.1016/S0140-6736(76)90218-X
Irwin, 1975, Enhanced resistance to Corynebacterium pseudotuberculosis infections associated with reduced serum immunoglobulin levels in levamisole-treated mice, Infect. Immun., 12, 1098, 10.1128/IAI.12.5.1098-1103.1975
Johnson, 1975, Effects of levamisole (NSC-177023) and tetramisole (NSC-102063) in experimental tumor systems, Cancer Chemother. Rep., 59, 697
Kenyon, 1976, Separation of aleutian disease antibody response from induction of gammapathy with levamisole, Fedn Proc., 35, 569
Kulkarni, 1973, Im-munostimulating effect of tetramisole on antibody formation against Newcastle disease virus in chicks, Indian vet. J., 50, 225
Leca, 1976, Agranulocytose au cours d’une polyarthrite rhumatoide traitée par le levamisole, Nouv.,Press Med., 5, 1212
Lequesne, 1976, Les effets secondaires au cours des traitements prolongés par le levamisole notamment dans les polyarthrites, Nouv. Press Med., 5, 358
Levo, 1975, Restoration of cellular immune response by levamisole in patients with Hodgkin's disease, Biomedicine, 23, 198
Lichtenfeld, 1974, Amplification of immunologically induced lymphocyte 3H thymidine incorporation by levamisole, Fedn Proc., 33, 790
Lichtenfeld, 1976, Modulating effects of levamisole (NSC-177023) on human lymphocyte response in vitro, Cancer Treat. Rep., 60, 571
Lieberman, 1976, Levamisole-mediated restoration of cellular immunity in peripheral blood lymphocytes of patients with immunodeficiency diseases, Clin. Immun. Immunopath., 5, 142, 10.1016/0090-1229(76)90157-4
Lima, 1974, Immunological phagocytosis: effect of drugs on phosphodiesterase activity, Experientia, 30, 945, 10.1007/BF01938377
Ling, 1975
Lorette, 1976, Maladie de Duhring-Brocq et pemphigus vulgaire: données actuelles
Mantovani, 1975, Allogeneic tumor enhancement by levamisole a new im-munostimulatory compound: studies on cell-mediated immunity and humoral antibody response, Eur. J. Cancer, 11, 537, 10.1016/0014-2964(75)90125-5
Merluzzi, 1975, Stimulation of mouse spleen cells in vitro by levamisole, Fedn Proc., 34, 1004
Merluzzi, 1975, In vitro stimulation of murine lymphoid cell cultures by levamisole, Clin. Exp. Immun., 22, 486
Merluzzi, 1976, Differential effects of levamisole on murine lymphoid tissues, Fedn. Proc., 35, 334
Moncada-Gonzales, 1976, Effect of levamisole on E rosettes, New Engl. J. Med., 295, 230, 10.1056/NEJM197607222950422
Nebert, 1972, Genetic regulation of aryl hydrocarbon hydroxylase induction in the mouse, Fedn Proc., 31, 1315
Nelson, 1976
Pabst, 1974, Enhancement of in vitro cellular immune response by L-tetramisole, Pediatr. Res., 8, 416, 10.1203/00006450-197404000-00459
Pabst, 1975, L-tetramisole enhancement of human lymphocyte response to antigen, Clin. Exp. Immun., 21, 468
Parker, 1974, Cyclic AMP and the immune response, 4, 1
Pasquier, 1975, Action du levamisole sur la restauration de l’immunité cellulaire chez l’homme, Nouv. Presse Med., 4, 2736
Perk, 1975, Some aspects of host response to levamisole after chemotherapy in a murine leukemia, J. natn. Cancer Inst., 54, 253, 10.1093/jnci/54.1.253
Plommet, 1970, Brucellose bovine expérimentale. I. Comparaison de l’efficacité des vaccins B19 et H38, Ann. Rech. vet., 1, 189
Potter, 1974, Levamisole'inactive in treatment of four animal tumours, Nature, 249, 567, 10.1038/249567a0
Provost, 1974, Recherche de l’activité immunostimulante de trois dérivés à action antihelminthique de l’imidazole sur les immunogeneses bovipestique, peripneumonique et charbonneuse, Revue Élev. Méd. vét. Pays trop., 27, 39
Raemaker, 1967, The absolute configuration of the optical isomers of the broad spectrum anti-helminthic, tetramisole, Tetrahedron Lett., 16, 1467, 10.1016/S0040-4039(00)90983-3
Ramot, 1976, Effect of levamisole on E-rosette- for'ming cells in vivo and in vitro in Hodgkin's disease, New Engl. J. Med., 294, 809, 10.1056/NEJM197604082941504
Reinke, 1976, Induction of rat hepatic mixed function monooxygenase by levamisole, Res. Comm. Chem. Path. Pharmac., 15, 397
Renoux, 1951, Traitement de la brucellose (B. melitensis) expérimentale du cobaye par le BAL (2, 3 dimercaptopropanol ou dithioglycerol) seul ou associé au chloramphenicol ou à l’aureomycine, Annis Inst. Pasteur, 81, 541
Renoux, 1969, Interférences chez la souris de l’infection par Coxiella bumeti avec la résistance ou l’immunité contre l’épreuve par Brucella abortus, C.R. Acad. Sci., 269, 1467
Renoux, 1971, Effet immunostimulant d’un imidothiazole dans l’immunisation des souris contre l’infection par Brucella abortus, C.R. Acad. Sci., 272D, 349
Renoux, 1972, Action immunostimulante de dérivés du phenylimidothiazole sur les cellules spléniques formatrices d’anticorps, C.R. Acad. Sci., 274D, 756
Renoux, 1977, Levamisole therapy in advanced cancer patients. A prognostic test?, 235
Renoux, 1977, Thymus-like activities of sulphur derivatives on T-cell differentiation, J. exp. Med., 145, 466, 10.1084/jem.145.2.466
Renoux, 1977, Influence du levamisole sur la production d’anticorps, Ann. Immun., 128C, 273
Renoux, 1977, Mécanismes d’action du levamisole, stimulant des réponses d’immunité cellulaire, Ann. Immun., 128C, 275
Renoux, 1977, Le diethyldithiocarbamate de soude est un stimulant de l’immunité, C.R. Soc. Biol., 171, 313
Renoux, 1968, Hemagglutination après couplage par le chlorure de chrome d’une glycoproteine bactérienne; échec de la benzidine, Annls. Inst. Pasteur, 115, 978
Renoux, 1972, Brucellose bovine expérimentale. X. Hémagglutinations passives après infection conjonctivale par Brucella abortus, Ann. Rech. vet., 3, 5
Renoux, 1975, Genetic control of immune responsiveness of mice to a soluble Brucella abortus antigen, 155
Renoux, 1976, Hémagglutination passive, transformation lymphoblastique et migration des leucocytes appliquées au diagnostic des brucelloses, 31, 145
Riley, 1975, Mouse mammary tumors: alteration of incidence as apparent function of stress, Science, 189, 465, 10.1126/science.168638
Rojas, 1976, Levamisole in advanced human breast cancer, Lancet, i, 211, 10.1016/S0140-6736(76)91337-4
Rosenthal, 1976, Leucocytotoxic effect of levamisole, Lancet, i, 369, 10.1016/S0140-6736(76)90133-1
Rosenthal, 1976, The effect of levamisole on peripheral blood lymphocyte subpopulations in patients with rheumatoid arthritis and ankylosing spondylitis, Clin. Exp. Immun., 25, 493
Ruuskanen, 1976, Levamisole and agranulocytosis, Lancet, ii, 958, 10.1016/S0140-6736(76)90916-8
Sadowski, 1975, Inhibition by levamisole of metastases by cells transformed by herpes simplex virus type I, Proc. Soc. exp. Biol. Med., 149, 219, 10.3181/00379727-149-38776
Sampson, 1976, The effect of levamisole on cell-mediated immunity and suppressor cell function, Cancer Res., 36, 952
Sany, 1976, Agranulocytose au cours de traitements par levamisole, Nouv. Presse Med., 5, 1148
Scheid, 1975, Differentiation of T-cells in nude mice, Science, 190, 1211, 10.1126/science.1081736
Schmidt, 1976, Effects of levamisole on human monocyte function and immunoprotein receptors, Clin. Immun. Immunopath., 6, 279, 10.1016/0090-1229(76)90082-9
Schmied, 1973, Effectos del levamisole sobre el indice de sueroprotection en primo vaccinaction antiaftosa, Rev. med. vet., 54, 467
Schreiber, 1975, Effect of levamisole on the human monocyte IgG. receptor, Blood, 46, 1018
Simkins, 1972, Disappearance of levamisole from bovine tissues, J. Anim. Sci., 35, 194
Stecher, 1976, Effect of levamisole on adherence and chemotaxis of leukocytes, Fedn Proc., 35, 531
Steel, 1974, The sheep-cell rosette test on human peripheral blood lymphocytes: an analysis of some variable factors in the technique, Br. J. Haemal., 28, 245, 10.1111/j.1365-2141.1974.tb06659.x
Strom, 1973, Modulation of lymphocyte blast transformation by cyclic mononucleotides, J. clin. Invest., 52, 83
1975, Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial, Br. med. J., 3, 461, 10.1136/bmj.3.5981.461
Sunshine, 1974, Levamisole and Imidazole: in vitro effects in mouse and man and their possible mediation by cyclic nucleotides, 31
Symoens, 1976, Le levamisole, une chimiothérapeutique antianergique, Louvain Méd., 95, 383
Szpilman, 1976, Levamisole and cell-mediated immunity and serum-immunoglobulins in rheumatoid arthritis, Lancet, ii, 208, 10.1016/S0140-6736(76)92393-X
Thienpont, 1966, Tetramisole (R8299), a new, potent broad spectrum anthelmintic, Nature, 209, 1084, 10.1038/2091084a0
Thiry, 1975, Comparison of the immunogenicity of hamster cells transformed by adenovirus and herpes simplex virus, Cancer Res., 35, 1022
Triglia, 1976, Effect of levamisole on Hamster melanoma, Fedn Proc., 35, 786
Tripodi, 1973, Drug-induced restoration of cutaneous delayed hypersensitivity in anergic patients with cancer, New Engl. J. Med., 289, 354, 10.1056/NEJM197308162890707
Van Belle, 1976, Alkaline phosphatase. I. Kinetics and inhibition by levamisole of purified isoenzymes from humans, Clin. Chem., 22, 972, 10.1093/clinchem/22.7.972
Van Belle, 1972, Kinetics and inhibition of alkaline phosphatases from canine tissues, Biochim. Biophy. Acta, 289, 158, 10.1016/0005-2744(72)90118-0
Van den Bossche, 1972, Biochemical effects of Tetramisole, 117
Van den Bossche, 1969, The biochemical mechanism of action of the antinematodal drug tetramisole, Biochem. Pharmac., 18, 35, 10.1016/0006-2952(69)90006-9
Van den Bossche, 1969, Studies on the carbohydrate metabolism of third-stage Haemonchus Contortus larvae, Life Sci., 8, 1047, 10.1016/0024-3205(69)90456-1
Van Eygen, 1976, Levamisole in prevention of recurrent upper-respiratory-tract infections in children, Lancet, i, 382, 10.1016/S0140-6736(76)90214-2
Van Ginckel, 1976, Effects of levamisole on spontaneous rosette-forming cells in murine spleen, Eur. J. Immun., 6, 305, 10.1002/eji.1830060414
Van Nueten, 1972, Pharmacological aspects of tetramisole, 101
Verhaegen, 1973, Immune responses in elderly cuti-negative subjects and the effect of levamisole, Verhandlungen der Deutschen Gasellschaft für innere Medizin, 79, 623, 10.1007/978-3-642-47087-5_162
Verhaegen, 1974, Effets du levamisole sur les réactions cutanées d’hypersensibilité retardée, Nouv. Presse Med., 3, 2483
Verhaegen, 1975, In vitro restoration by levamisole of thymus-derived lymphocyte function in Hodgkin's disease, Lancet, i, 978, 10.1016/S0140-6736(75)92040-1
Versup, 1975, Levamisole and functions of peritoneal macrophages, Lancet, i, 798
Vitetta, 1975, Immunoglobulin-receptors revisited, Science, 189, 964, 10.1126/science.1083069
Wachi, 1974, Effect of levamisole and C-reactive protein on mitogen-stimulated lymphocytes in vitro, Res. Comm. Chem. Path. Pharmac., 8, 681
Weber, 1976, Effects of leukoagglutinating phytohemagglutinin on cAMP and cGMP levels in lymphocytes, Expl. Cell. Res., 97, 432, 10.1016/0014-4827(76)90637-6
Whitcomb, 1976, The effect of levamisole on human lymphocyte mediator production in vitro, Cellular Immun., 218, 272, 10.1016/0008-8749(76)90056-3
Wjluams, 1976, Levamisole and agranulocytosis, Lancet, i, 1080
Woods, 1974, In vitro stimulation of spleen cell cultures by poly I:poly C and levamisole, Cellular Immun., 14, 327, 10.1016/0008-8749(74)90217-2
Woods, 1975, Effect of levamisole on the in vitro immune response of spleen: lymphocytes, Proc. Socv exp. Biol. Med., 148, 1048, 10.3181/00379727-148-38686
Woods, 1975, Effect of levamisole (NSC-177023) on DNA synthesis by lymphocytes from immunosuppressed C57BL mice, Cancer Chemother Rep, 59, 531
Yunis, 1975, Immune deficiency, auto-immunity and aging, 185
Allen, 1975, Levamisole therapy for recurrent herpes simplex and aphthous stomatitis
Amery, 1975, Levamisole, Lancet, i, 574
Amery, 1976, Levamisole (NSC-177023) in clinical immunotherapy, Cancer Treatment Rep., 60, 217
Basch, 1975, The effects of levamisole in rheumatoid arthritis, Arthritis Rheum., 18, 385
Bensa, 1976, Levamisole in angio-immunoblastic lymphadenopathy, Lancet, i, 1081, 10.1016/S0140-6736(76)92262-5
Brugmans, 1973, Restoration of host defense mechanism in man by levamisole, Life Sci., 13, 1499, 10.1016/0024-3205(73)90137-9
Cardama, 1973, Study of the immunostimulating action of levamisole in leprosy, Int. J. Lepr., 16, 567
Chmel, 1973, Levamisole and the immune response, New Engl. J. Med., 289, 1149
Churchill, 1973, Levamisole and cell-mediated immunity, New Engl. J. Med., 289, 375, 10.1056/NEJM197308162890715
Dau, 1976, The effect of levamisole on cellular immunity in multiple sclerosis, Clin. Exp. Immun., 26, 302
De Cree, 1974, The effect of levamisole on the immunologic response of HBAG positive patients, Digestion, 10, 306
Dinai, 1975, Levamisole in rheumatoid, arthritis, Lancet, ii, 556, 10.1016/S0140-6736(75)90934-4
Fischer, 1974, Enhanced host defense mechanisms with phenyl-imidothiazole, Pediatr. Res., 8, 4, 10.1203/00006450-197404000-00435
Fischer, 1975, Immunopotentiation by levamisole, Lancet, i, 1137, 10.1016/S0140-6736(75)92523-4
Flannery, 1975, Levamisole, Lancet, i, 750, 10.1016/S0140-6736(75)91665-7
Gréco, 1975, Intérêt du levamisole dans le traitement des brûlés. Note préliminaire, J. Chir. Tours et C.O., 9, 155
Helin, 1974, Levamisole for warts, New Engl. J. Med., 291, 1311, 10.1056/NEJM197412122912420
Hirshaut, 1974, Trial of levamisole as immunopotentiator in cancer patients, Proc. Am. Ass. Cencer Res., 15, 126
Hopper, 1975, Levamisole, Lancet, i, 574
Ippen, 1975, Levamizol zur behandlung von kautkrenkheiten, Dt. med. Wschr., 100, 1710
Kint, 1974, Levamisole for recurrent herpes labialis, New Engl. J. Med., 291, 308, 10.1056/NEJM197408082910614
Kint, 1974, Essai du levamisole dans le traitement de l’herpès récidivant, Bull. Soc. fr. Derm. Syph., 01, 627
Leca, 1976, Vingt cas de polyarthrite rhumatoide traités par le levamisole, Nouv. Presse Med., 5, 89
Lods, 1975, Zona ophtalmique chez l’enfant. Essai de traitement par stimulation macrophagique, Bull. Soc. Ophtal. Fr., 75, 37
Lods, 1976, Traitement de l’herpès cornéen récidivant et des zonas ophtalmiques par le levamisole, Nouv. Presse Med., 5, 148
Marx, 1976, Cancer immunotherapy: focus on the drug levamisole, Science, 191, 57, 10.1126/science.191.4222.57
McGill, 1976, Levamisole in rheumatoid arthritis, Lancet, i, 149, 10.1016/S0140-6736(76)93191-3
Meyers, 1975, Failure of levamisole to alter the lepromin reaction, Am. J. Trop. Med. Hyg., 24, 857, 10.4269/ajtmh.1975.24.857
Olson, 1976, Levamisole: a new treatment for recurrent aphthous stomatitis, Oral Surg., 41, 588, 10.1016/0030-4220(76)90311-X
Pabst, 1975, Levamisole, Lancet, i, 574, 10.1016/S0140-6736(75)91592-5
Pasricha, 1971, Skin rash as a side effect of 1-tetramisole, Toxic applied. Pharmac., 20, 602, 10.1016/0041-008X(71)90266-3
Peters, 1976, Levamisole in the treatment of cancer, Lancet, i, 1020, 10.1016/S0140-6736(76)91892-4
Rosenthal, 1976, Levamisole in sarcoidosis, New Engl. J. Med., 294, 112, 10.1056/NEJM197601082940216
Runne, 1975, Levamizol zur behandlung von rezidivierendem herpes simplex oder malignem melanom?, Dt. med. Wschr., 48, 2510
Saint-André, 1976, Stimulation de l’immunité cellulaire dans la lèpre lépromateuse par levamisole, Méd. armées, 4, 223
Schuermans, 1975, Levamisole in rheumatoid arthritis, Lancet, i, 111, 10.1016/S0140-6736(75)91127-7
Schuermans, 1976, Le traitement de la polyarthrite rhumatoide par le levamisole, Revue Rhum., 43, 437
Sewell, 1976, Levamisole for rheumatoid arthritis, Lancet, i, 651, 10.1016/S0140-6736(76)90473-6
Symoens, 1974, Treatment of recurrent aphthous stomatitis and herpes with levamisole, Br. med. J., 4, 592, 10.1136/bmj.4.5944.592
Szpilman, 1976, Levamisole and cell-mediated immunity and serum-immunoglobulins in rheumatoid arthritis, Lancet, ii, 208, 10.1016/S0140-6736(76)92393-X
Trabert, 1975, Levamizol bei der behandlung entwündlich-rheumatischer erkrankungen und der Sarkoidose, Dr. med. Wschr., 100, 2297
Trabert, 1976, Therapie entzündlich-rheumatischer krankheiten mit levamizol einer immunmodulierenden substantz, Schweiz, med. Wschr., 106, 1293
Van Heule, 1976, Levamisole therapy for cellular immunologic deficiency with high IgE values, Acta pediat. Belgica, 29, 41
Verhaegen, 1973, Treatment of aphthous stomatitis, Lancet, ii, 842, 10.1016/S0140-6736(73)90879-9
Verhaegen, 1973, Levamisole and the immune response, New Engl. J. Med., 289, 1148, 10.1056/NEJM197311222892121
Veys, 1976, Levamisole in rheumatoid arthritis, Lancet, i, 808, 10.1016/S0140-6736(76)91651-2
Wachi, 1975, Mechanism of levamisole effect on warts, New Engl. J. Med., 292, 483, 10.1056/NEJM197502272920921
Webster, 1975, Levamisole, Lancet, i, 389, 10.1016/S0140-6736(75)91296-9
Webster, 1975, Levamisole, Lancet, i, 917, 10.1016/S0140-6736(75)91715-8
Webster, 1976, Levamisole—A double blind immunological study, Br. J. Cancer, 34, 319
Yaron, 1976, Levamisole in rheumatoid arthritis, Lancet, i, 369, 10.1016/S0140-6736(76)90132-X
